JP2005526016A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526016A5
JP2005526016A5 JP2003561581A JP2003561581A JP2005526016A5 JP 2005526016 A5 JP2005526016 A5 JP 2005526016A5 JP 2003561581 A JP2003561581 A JP 2003561581A JP 2003561581 A JP2003561581 A JP 2003561581A JP 2005526016 A5 JP2005526016 A5 JP 2005526016A5
Authority
JP
Japan
Prior art keywords
dna
delivery device
drug delivery
stabilized
supercoiled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003561581A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526016A (ja
Filing date
Publication date
Priority claimed from GBGB0201736.6A external-priority patent/GB0201736D0/en
Application filed filed Critical
Publication of JP2005526016A publication Critical patent/JP2005526016A/ja
Publication of JP2005526016A5 publication Critical patent/JP2005526016A5/ja
Pending legal-status Critical Current

Links

JP2003561581A 2002-01-25 2003-01-23 Dnaの投薬形態 Pending JP2005526016A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0201736.6A GB0201736D0 (en) 2002-01-25 2002-01-25 DNA dosage forms
PCT/GB2003/000282 WO2003061636A2 (en) 2002-01-25 2003-01-23 Dna dosage forms

Publications (2)

Publication Number Publication Date
JP2005526016A JP2005526016A (ja) 2005-09-02
JP2005526016A5 true JP2005526016A5 (https=) 2006-02-09

Family

ID=9929749

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003561581A Pending JP2005526016A (ja) 2002-01-25 2003-01-23 Dnaの投薬形態

Country Status (10)

Country Link
US (1) US20050080028A1 (https=)
EP (1) EP1467720B1 (https=)
JP (1) JP2005526016A (https=)
AT (1) ATE427105T1 (https=)
AU (1) AU2003202685A1 (https=)
CA (1) CA2473679A1 (https=)
DE (1) DE60326930D1 (https=)
ES (1) ES2322572T3 (https=)
GB (1) GB0201736D0 (https=)
WO (1) WO2003061636A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
WO2005020912A2 (en) 2003-08-25 2005-03-10 3M Innovative Properties Company Delivery of immune response modifier compounds
BRPI0415850A (pt) * 2003-10-23 2007-01-02 Alza Corp composição de dna estabilizado para o revestimento de micro projeções
US7591806B2 (en) * 2004-05-18 2009-09-22 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
EP2272430A1 (en) 2004-08-16 2011-01-12 Functional Microstructures Limited Method of producing a microneedle or microimplant
US8048017B2 (en) * 2005-05-18 2011-11-01 Bai Xu High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
US8043250B2 (en) * 2005-05-18 2011-10-25 Nanomed Devices, Inc. High-aspect-ratio microdevices and methods for transdermal delivery and sampling of active substances
CN101227940A (zh) * 2005-07-25 2008-07-23 纳米技术维多利亚有限公司 微阵列装置
CA2629193C (en) 2005-11-18 2016-03-29 3M Innovative Properties Company Coatable compositions, coatings derived therefrom and microarrays having such coatings
US10525246B2 (en) 2006-12-22 2020-01-07 Nanomed Skincare, Inc. Microdevice and method for transdermal delivery and sampling of active substances
US20080214987A1 (en) * 2006-12-22 2008-09-04 Nanomed Devices, Inc. Microdevice And Method For Transdermal Delivery And Sampling Of Active Substances
US8512679B2 (en) 2011-03-04 2013-08-20 Elwha Llc Glassy compositions
CN103717249B (zh) 2011-06-15 2017-03-22 克洛恩泰克制药股份公司 注射针和装置
KR101314091B1 (ko) * 2011-07-26 2013-10-04 연세대학교 산학협력단 치료 부위내 경피 유전자 전달을 위한 일렉트로 마이크로니들 집적체 및 이의 제조방법
JP2013052202A (ja) * 2011-09-01 2013-03-21 Kosumedei Seiyaku Kk Dnaワクチンマイクロニードル
US10064960B2 (en) * 2011-11-25 2018-09-04 Danmarks Tekniske Universitet Formulation of solid nano-sized particles in a gel-forming system

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212924B (en) * 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
ATE235558T1 (de) * 1989-06-26 2003-04-15 Powderject Vaccines Inc Transformation von tierischen somatischen zellen mittels partikeln
US5697901A (en) * 1989-12-14 1997-12-16 Elof Eriksson Gene delivery by microneedle injection
JPH08510639A (ja) * 1993-04-19 1996-11-12 メディソーブ・テクノロジーズ・インターナショナル・リミテッド・パートナーシップ 細胞取込みと遺伝子発現の促進と標的化をもたらす接合体と核酸のカプセル化
US5804566A (en) * 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
AU705889B2 (en) * 1993-08-26 1999-06-03 Regents Of The University Of California, The Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory peptides
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
ES2208687T3 (es) * 1994-08-04 2004-06-16 Elan Drug Delivery Limited Sistema de administracion de sustancias solidas para la liberacion controlada de moleculas incorporadas en tales sustancias y procedimientos para la fabricacion de tales sistemas.
EP0906110B1 (en) * 1996-04-26 2004-12-22 Merck & Co., Inc. Dna vaccine formulations
EP1100579B1 (en) * 1998-07-13 2015-09-02 Inovio Pharmaceuticals, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
US6713291B2 (en) * 1999-01-28 2004-03-30 Alan D. King Electrodes coated with treating agent and uses thereof
EP1163024B1 (en) * 1999-01-28 2003-12-17 Cyto Pulse Sciences, Inc. Delivery of macromolecules into cells
US6743211B1 (en) * 1999-11-23 2004-06-01 Georgia Tech Research Corporation Devices and methods for enhanced microneedle penetration of biological barriers
US6835184B1 (en) * 1999-09-24 2004-12-28 Becton, Dickinson And Company Method and device for abrading skin
US20020002136A1 (en) * 2000-06-28 2002-01-03 Hebert Rolland F. Salts of glutathione
EP1299087A1 (en) * 2000-07-07 2003-04-09 Corixa Corporation Microspheres and adjuvants for dna vaccine delivery
GB0017999D0 (en) * 2000-07-21 2000-09-13 Smithkline Beecham Biolog Novel device
NZ529029A (en) * 2001-04-20 2005-07-29 Alza Corp Microprojection array having a beneficial agent containing coating

Similar Documents

Publication Publication Date Title
JP2005526016A5 (https=)
JP2007302683A5 (https=)
CA2319872A1 (en) Pharmaceutical composition for the treatment of hepatocellular carcinoma
CA2515293A1 (en) Eicosapentaenoic acid for use in improving prognosis in the treatment of subarachnoid hemorrhage
JP2004502756A5 (https=)
JP2019523214A5 (https=)
JP2005537234A5 (https=)
JP2007526238A5 (https=)
JP2013542264A5 (https=)
JP2005538045A5 (https=)
WO2004103283A3 (en) Compositions of a cyclooxygenase-2 selective inhibitor and a central nervous system stimulant for the treatment of central nervous system damage
JP2020502116A5 (https=)
JP2009517411A5 (https=)
WO2002000239A1 (en) Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same
JP2005519905A5 (https=)
JP2020536098A5 (https=)
DE60119905D1 (de) Verfahren zur herstellung fester dispersionen
IS8430A (is) Lyf sem inniheldur (2R)-2-própýloktansýru sem virka efnisþáttinn
WO2001028589A3 (de) Formkörper mit amphiphilen äusseren phase und lipophilen inneren phase
WO2002034240A3 (en) Delayed and sustained release formulations and method of use thereof
JP2005511708A5 (https=)
RU2018107057A (ru) Фрамацевтическая композиция с улучшенной устройчивостью при хранении и способ ее получения
EP1905449A3 (en) Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
WO2007034287A3 (en) Oramucosal pharmaceutical dosage form
RU2018107052A (ru) Фармацевтическая композиция с улучшенной устойчивостью при хранении и способ ее получения